← Blog

Cannabis Brands and China: An Emerging IP Challenge

Explore the emerging intellectual property challenges for cannabis brands in China. Understand the risks and strategies for protecting your brand.

Home | Canna Law Blog | Cannabis Brands and China: An Emerging IP Challenge Table of Contents Toggle Cannabis Brands and China Challenges Cannabis brands account for a sizeable component of my law firm’s intellectual property work (and, indeed, our work generally). Historically, there has been little overlap between our cannabis and China practice areas, beyond our representing a number of cannabis ancillary product companies on their China manufacturing matters. This is starting to change, as we increasingly see bad-faith actors in China targeting cannabis brands’ trademarks. This intersection carries important implications that cannabis business owners need to understand. This post highlights the emerging IP challenges cannabis brands face from China and provides proactive strategies for cannabis brands to fight back. China Trademark Squatting We can only speculate about what is driving this emerging phenomenon. Most likely, it is partly a new manifestation of an old China problem: trademark squatters. Trademark squatters in China now recognize that, much like other brands, cannabis brands also source various products from the country. Obviously we are not talking about cannabis or cannabis derivatives, but rather goods such as vapes, trimmers, merch, packaging, cosmetics, etc. Squatters generally register trademarks being used by brands like yours in the hope that eventually you will pay them to acquire control over “your” trademarks. And guess what, squatting often works, with payout of tens of thousands of dollars common, and larger payouts not unheard of. For cannabis (and other) brands that source products from China, a squatter to their trademarks can be a huge problem. Chinese trademark squatters often use their trademark rights to get Chinese law enforcement to seize your products, halt your production, or block your exports, all with the ultimate goal of forcing you to buy the China trademark of your brand from them. To avoid such problems, cannabis brands with any China exposure should vigilantly monitor trademark applications and oppose any suspicious registrations. Even better, they should register their brand names as China trademarks ahead of squatters, to ensure they remain one step ahead in this strategic game. If a squatter does manage to register your brand’s trademarks, your options will become more limited, especially during the first three years following this registration; after three years, there’s a good chance the squatted trademarks will be vulnerable to a cancellation petition on the basis of non-use. Moreover, there’s an added dimension to consider: the real-world counterparts of these bad-faith actors. They could very well be manufacturers you’ve previously engaged with or have shared sensitive information. The threats could also emanate from rogue employees within your manufacturer’s fold or even affiliated manufacturers. In these complex, high-stakes scenarios, the optimal strategy often entails going on the offensive. Early discovery of such deceit during the trademark application phase allows brands to oppose the registration. But as highlighted, post-registration, the available strategic moves are far fewer. Brands not sourcing from China aren’t entirely in the clear. Though they face a diminished threat from China trademark squatters, other bad-faith actors are waiting in the wings. In certain instances, these actors may register your brand’s trademarks in China with genuine intent to use them. Even if you don’t manufacture your products in China, there’s probably a manufacturer there that can produce your product and nothing stops such manufacturers from collaborating with entities that have unfairly registered your trademarks. To mitigate the risk of China-made counterfeits of your products entering the U.S. (or Canada or other markets), cannabis brands need to register their trademarks in their primary sales markets. They should also take the additional step of recording their trademark with U.S. Customs and Border Protection (CBP) or the customs authorities in the country in question, to help prevent the entry of counterfeits. Of course, the risks posed by someone who is actually using trademarks obtained in bad faith is far greater for cannabis brands that are getting products from China. In addition to shipping counterfeits, bad-faith trademark registrants often engage in the same kind of hijinks as squatters, such as petitioning China law enforcement to shut down your production. Also, keep in mind that the counterfeiter actor might be the manufacturer with whom you have been working, sharing confidential information, or a rogue employee of your manufacturer, or a manufacturer related to yours. For cannabis brands that find themselves (or could find themselves) in such a high-stakes situations, it is likely that the only sensible option is going on the offensive and mounting a challenge to the bad-faith actor. Ideally, you will find out about the shenanigans during the trademark application process, when you can oppose registration of the trademark. As discussed, options will be more limited after registration. Conclusion The merging of cannabis brands with China’s IP landscape introduces new challenges. Simultaneously, the need for cannabis brands to protect their intellectual property has become increasingly important. Being proactive is crucial; understanding potential threats, and arming yourself with the right tools and knowledge can make all the difference. Ensure you have adequate protections in place not just in your home market, but possibly in China as well. If a squatter or counterfeiter has already secured rights over your brand’s trademarks, be prepared to go on the offensive. Editor's Note: This piece first ran on our firm's China Law Blog on August 28, 2023. Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Fred Rocafort Fred leads Harris Sliwoski’s intellectual property practice and is the coordinator of the firm’s international team. Much of Fred’s practice consists of helping cannabis businesses protect their brands. He also works with entrepreneurs and companies entering the Web3 space, a new frontier for IP law. Prior to joining Harris Sliwoski, Fred worked overseas for more than a decade, in both government and private sector roles. Fred is a regular contributor to the award-winning China Law Blog and Canna Law Blog. Fred began his career overseas as a U.S. consular officer in Guangzhou, China, where he advocated for fairer treatment of American companies and citizens in China and for stronger intellectual property rights enforcement. After entering the private sector, Fred worked at a Shanghai law firm as a foreign legal advisor and later joined one of the oldest American law firms in China, helping foreign companies navigate the Chinese legal environment. He also led the legal team at a Hong Kong-based brand protection consultancy, spending most of his time out in the field, protecting clients against counterfeiters and fraudsters in Greater China, Southeast Asia and Latin America. In addition to his IP work, as a native Spanish speaker, Fred works closely with different Harris Sliwoski teams on Latin America and Spain matters. Fred also provides advice to cannabis industry participants and other businesses on import and export transactions. Fred is an ardent supporter of FC Barcelona—and would be even in the absence of Catalan forebears who immigrated to Puerto Rico in the mid-1800s. Harris Sliwoski Attorney Read more posts [email protected] Read More Intellectual Property/Branding, International Cannabis Law Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply